Latest Regulatory Approval News

Bathurst Resources reported a first-half FY26 EBITDA of NZD 16 million, maintaining its full-year guidance despite export challenges and cost pressures. Key development projects in New Zealand and Canada continue to advance steadily.

Estrella Resources has reported multiple high-grade manganese intersections at its Ira Miri project, including assays up to 58% manganese, and received regulatory approval for a 30,000-tonne bulk sample extraction. Concurrently, drilling at the Werumata limestone project has been completed with assay results pending.

Po Valley Energy has adopted its first-ever dividend policy and announced plans to pay a maiden dividend, signalling confidence in its cash flow and future growth prospects.

Audio Pixels has validated a major technical milestone for its digital MEMS speaker array and raised $1.25 million through convertible notes, while securing a $6 million funding commitment to support ongoing development amid continued ASX trading suspension.

Artrya Limited has converted three US foundation partners into commercial customers, generating its first fee-per-scan revenues, while progressing FDA clearance for its Salix Coronary Flow module and expanding its clinical study network.

Medallion Metals has completed a pivotal feasibility study for its Ravensthorpe Gold Project and raised $60 million to accelerate development, while progressing a key acquisition of Forrestania assets.

Peninsula Energy reports strong progress at its Lance Uranium Project in Wyoming, with key production milestones reached and the company on track to meet 2026 uranium output targets amid a buoyant market.

OncoSil Medical has reported a record quarter for dose sales alongside key European market entries and a successful manufacturing milestone, signalling growing momentum for its pancreatic cancer treatment.

CuFe Ltd has raised $5.4 million through a strategic placement and upgraded its Tennant Creek resource to include valuable critical minerals, setting the stage for a major drilling campaign.

Imugene Limited has reported compelling clinical trial results for its off-the-shelf CAR T therapy, azer-cel, alongside FDA validation and a strategic collaboration, while managing cash flow amid cost reductions.

Kingsland Minerals has completed a pivotal scoping study for its Leliyn Graphite Project, confirming high-grade purified spherical graphite production potential. The company also secured $2.16 million through a placement and share purchase plan and has commenced a pre-feasibility study.

Terragen Holdings reports a strong quarter with an 87% increase in sales of its ruminant probiotic and advances key livestock and crop trials, positioning itself for expanded market access.